SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-056277
Filing Date
2009-11-03
Accepted
2009-11-03 16:58:01
Documents
5
Period of Report
2009-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v164475_8k.htm 8-K 40343
2 v164475_ex10-1.htm EX-10.1 147178
3 v164475_ex10-2.htm EX-10.2 46308
4 v164475_ex99-1.htm EX-99.1 11300
5 v164475_ex99-2.htm EX-99.2 11813
  Complete submission text file 0001144204-09-056277.txt   258904
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15281 | Film No.: 091155125
SIC: 2836 Biological Products, (No Diagnostic Substances)